Abstract: A method of making a lithium alkylsiliconate composition comprising adding an alkylalkoxysilane to a first mixture comprising lithium hydroxide and water to form a second mixture comprising a lithium alkylsiliconate and an alcohol, wherein i) the mole ratio of lithium hydroxide to alkylalkoxysilane is from 0.9 to less than 1.1 and the water is from 89 to 93 mol %, or ii) the mole ratio of lithium hydroxide to alkylalkoxysilane is from 1.1 to 1.4 and the water is from greater than 93 to 99 mole %.

Abstract: The present invention generally relates to bacterial polypeptide display systems, libraries using these bacterial display systems, and methods of making and using these systems, including methods for improved display of polypeptides on the extracellular surface of bacteria using circularly permuted transmembrane bacterial polypeptides that have been modified to increase resistance to protease degradation and to enhance polypeptide display characteristics.

Abstract: A condensation cooling system for motor vehicles is presented. The system, in principal pan, comprises a liquid-to-liquid heat exchanger for circulating a first coolant, a coolant tank for circulating a second coolant, and a condensing panel or surface, where the condensing panel is pan of the coolant tank and also functions as a vehicle body panel. These components are arranged in two circuits, i.e. an engine cooling circuit in which a first coolant is circulated and a vapor condensing circuit in which a second coolant is circulated. The two cooling circuits are interconnected by the coolant tank where the heat exchanger is positioned within the coolant tank such that it is immersed in the second coolant. The coolant tank may also be equipped with pressure release valves, electric fans and diffuser plates to control pressure and manage air and vapor flow internally within the tank.

Abstract: A process for separating solvent from a feed solution, said process comprising: contacting a feed solution comprising solutes dissolved in a solvent with one side of a nanofiltration membrane, applying hydraulic pressure to the feed solution, such that solvent and some of the dissolved salts from the feed solution flow through the nanofiltration membrane to provide a permeate solution on the permeate-side of the nanofiltration membrane and a concentrated solution on the retentate-side of the nanofiltration membrane; contacting the permeate solution from the nanofiltration membrane with one side of a reverse osmosis membrane and applying hydraulic pressure to the permeate solution, such that solvent from the permeate solution flows through the reverse osmosis membrane to leave a concentrated solution on the retentate-side of the reverse osmosis membrane, using the concentrated solution from the retentate-side of the reverse osmosis membrane as at least part of the feed solution to the nanofiltration membrane;

Abstract: An apparatus for reversibly fixing a medical apparatus to a vehicle, the apparatus comprising a fitting to engage with the vehicle, and a support wherein the support comprises means for reversible engagement with a medical apparatus and the arrangement of the fitting relative to the support is adjustable so as to enable reversible fixing of the apparatus to a plurality of vehicle configurations.

Abstract: The invention relates generally to antibodies that bind programmed death ligand 1 (PDL1), activatable antibodies that specifically bind to PDL1 and methods of making and using these anti-PDL1 antibodies and anti-PDL1 activatable antibodies in a variety of therapeutic, diagnostic and prophylactic indications.

Abstract: The invention relates generally to antibodies that bind programmed death ligand 1 (PDL1), activatable antibodies that specifically bind to PDL1 and methods of making and using these anti-PDL1 antibodies and anti-PDL1 activatable antibodies in a variety of therapeutic, diagnostic and prophylactic indications.

Abstract: The invention relates generally to activatable antibodies that include a masking moiety (MM), a cleavable moiety (CM), and an antibody (AB) that specifically binds to interleukin-6 receptor (IL-6R), and to methods of making and using these anti-IL-6R activatable antibodies in a variety of therapeutic, diagnostic and prophylactic indications.

Abstract: The disclosure relates to a tissue culture device and components of a system used to grow, maintain and measure recording from cells. In some embodiments, the tissue culture device is an insert with a surface onto which cells may be plated and grown. Electrodes on or near the surface of the cells can be used to measure electrophysiological data when current is applied to the system.

Abstract: A noise or vibration detection system includes a clamping device with an audio transducer and a wireless transmitter. The transmitter transmits the audio signal, or a modified version of the audio signal, from the transducer. A mobile device located remote from the transmitter receives the transmitted audio signal for processing. The mobile device includes a receiver configured to receive the audio signal, a display configured as a user interface and to display information to a user, a memory configured to store non-transient machine executable code, and a processor configured to execute the machine executable code stored on the memory. The machine executable code is configured to process the received signal to form an audio signal which is presented to a speaker of the mobile device or a headphone port of the mobile device and also display the audio signal in graphical form on the display.

Abstract: An appliance hub for use in an upper portion of an enclosure can include a substrate configured to be positioned in an upper portion of an enclosure. The appliance hub can include a climate control apparatus mounted on the substrate and the climate control apparatus can be configured to regulate a temperature within the enclosure. The appliance hub can include one or more lighting elements configured to provide light within the enclosure, a plurality of fluid lines connected to the substrate and configured to provide fluid service and return to the climate control apparatus, and/or a plurality of electrical connections connected to the substrate and configured to provide electrical power and/or data to at least one of the climate control apparatus and the one or more lighting elements.

Abstract: A poolside burner having a central gas feed and a burner ring having longitudinally-oriented slit-like flame orifices. The burner ring is securely attached to a burner plate having a centralized hole through which a feeder extends and mates with a central distribution tube connected to the burner ring.

Abstract: An outdoor decorative burner having a direct gas feed and a linear burner having a plurality of longitudinally-oriented slit-like flame orifices. The linear burner is securely attached to a plate by at least two wrap brackets. A direct spark igniter and a flame sensor are included and surrounded by protective cages.

Abstract: A writing instrument with a cap that lockingly engages a body portion via a locking assembly is presented herein. The locking assembly includes a pair of locking tabs on the cap that correspondingly fit within locking channels on the body of the writing instrument. With the tabs positioned within the locking channels, the cap is twisted or rotated such that the locking tabs slide past a node within the channels and restricts removal of the cap from the body portion.

Abstract: The invention relates generally to antibodies that bind programmed death ligand 1 (PDL1), activatable antibodies that specifically bind to PDL1 and methods of making and using these anti-PDL1 antibodies and anti-PDL1 activatable antibodies in a variety of therapeutic, diagnostic and prophylactic indications.

Abstract: The invention relates generally to polypeptides that include a cleavable moiety that is a substrate for at least one matrix metalloprotease (MMP), to activatable antibodies and other larger molecules that include the cleavable moiety that is a substrate for at least one MMP protease, and to methods of making and using these polypeptides that include a cleavable moiety that is a substrate for at least one MMP protease in a variety of therapeutic, diagnostic and prophylactic indications.

Abstract: The invention relates generally to polypeptides that include at least a first cleavable moiety (CM1) that is a substrate for at least one matrix metalloprotease (MMP) and at least a second cleavable moiety (CM2) that is a substrate for at least one serine protease (SP), to activatable antibodies and other larger molecules that include these polypeptides that include at least a CM1 that is a substrate for at least one MMP protease and at least a CM2 that is a substrate for at least one SP protease, and to methods of making and using these polypeptides that include at least a CM1 that is a substrate for at least one MMP protease and at least a CM2 that is a substrate for at least one SP protease in a variety of therapeutic, diagnostic and prophylactic indications.